Letter to the editor: Could COVID-19 vaccination reduce postinfection mortality in most patients with cirrhosis?

Lo, Gin-Ho

Lo, Gin-Ho.

Affiliation

Lo GH; Division of Gastroenterology, Department of Medicine , E-Da Hospital , Kaohsiung , Taiwan.

Hepatology ; 77(2): E32, 2023 02 01.

Article in En | MEDLINE | ID: mdl-36053792

Subject(s)

COVID-19; Humans; COVID-19/prevention & control; COVID-19 Vaccines; Liver Cirrhosis/complications; SARS-CoV-2; Vaccination

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538083
https://dx.doi.org/10.1002/hep.32751

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Hepatology Year: 2023 Type: Article Affiliation country: Taiwan

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538083
https://dx.doi.org/10.1002/hep.32751

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Hepatology Year: 2023 Type: Article Affiliation country: Taiwan